DCTH : Summary for Delcath Systems, Inc. - Yahoo Finance

U.S. Markets closed

Delcath Systems, Inc. (DCTH)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.06-0.00 (-1.17%)
At close: 4:00PM EDT
People also watch
CLSNCYCCETRMAEZSRNN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.06
Open0.06
Bid0.06 x 32600
Ask0.11 x 5800
Day's Range0.06 - 0.06
52 Week Range0.05 - 6.88
Volume8,905,827
Avg. Volume10,382,201
Market Cap6.99M
Beta1.51
PE Ratio (TTM)-0.01
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire2 days ago

    Delcath Issues Letter to Stockholders

    NEW YORK, April 27, 2017-- Delcath Systems, Inc., an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces that Jennifer K. Simpson, Ph.D., MSN, CRNP, ...

  • GlobeNewswire11 days ago

    Spire Southampton Hospital in UK Celebrating Over 100 CHEMOSAT Treatments

    NEW YORK, April 18, 2017-- Delcath Systems, Inc., an interventional oncology company focused on the treatment of primary and metastatic liver cancers, commended Spire Southampton Hospital on the performance ...

  • GlobeNewswirelast month

    Delcath Announces 2016 Financial Results

    NEW YORK, March 29, 2017-- Delcath Systems, Inc., an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces financial results for the 12 months ended ...